Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Iscience|February 22, 2024
The value of earlier-in-life systolic and diastolic blood pressure for cardiovascular risk predictionAndreas Leiherer, Wolfgang Brozek, Axel Muendlein, et al.
Melanoma Research|May 21, 2016
Serum levels of hepatocyte growth factor as a potential tumor marker in patients with malignant melanomaRainer Hügel, Axel Muendlein, Lennart Volbeding, et al.
Atherosclerosis|December 3, 2014
Angiopoietin-like protein 4 significantly predicts future cardiovascular events in coronary patientsAxel Muendlein, Christoph H Saely, Andreas Leiherer, et al.
Scientific Reports|June 17, 2022
Evaluation of the association of serum glypican-4 with prevalent and future kidney functionAxel Muendlein, Eva Maria Brandtner, Andreas Leiherer, et al.
The Pediatric Infectious Disease Journal|July 3, 2015
Confirmation of Host Genetic Determinants in the CFH Region and Susceptibility to Meningococcal Disease in a Central European Study SampleAriane Biebl, Axel Muendlein, Elena Kinz, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 6, 2025
Leucine-rich α-2 glycoprotein 1 is associated with increased mortality risk in patients with peripheral artery diseaseAxel Muendlein, Andreas Leiherer, Eva Maria Brandtner, et al.
Atherosclerosis|February 24, 2022
Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patientsAxel Muendlein, Eva Maria Brandtner, Andreas Leiherer, et al.
BMJ Open Diabetes Research & Care|November 16, 2021
Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery diseaseLukas Sprenger, Arthur Mader, Barbara Larcher, et al.
Pageof 9